A Second Opinion From Observational Data on Second-line Diabetes Drugs

JAMA Netw Open. 2018 Dec 7;1(8):e186119. doi: 10.1001/jamanetworkopen.2018.6119.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Cardiovascular Diseases*
  • Diabetes Mellitus, Type 2*
  • Humans
  • Hypoglycemic Agents
  • Referral and Consultation

Substances

  • Hypoglycemic Agents